Comparative molecular modeling study of the three-dimensional structures of prostaglandin endoperoxide H2 synthase 1 and 2 (COX-1 and COX-2)

被引:30
作者
Filizola, M
Perez, JJ
Palomer, A
Mauleón, D
机构
[1] Univ Politecn Catalunya, ETS Engn Ind, Dept Engn Quim, E-08028 Barcelona, Spain
[2] Univ Naples 2, Ctr Ric Interdipartimentale Sci Computaz & Biotec, Naples, Italy
[3] Labs Menarini, Badalona, Spain
关键词
PGHS; COX; NSAIDs; AMBER force field; homology modeling;
D O I
10.1016/S1093-3263(97)00107-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To understand the structural features that dictate the selectivity of diverse nonsteroidal antiinflammatory drugs for the two isoforms of the human prostaglandin H(2 )synthase (PGHS), the three-dimensiona1 (3D) structure of human COX-2 was assessed by means of sequence homology modeling. The ovine COX-2 structure, solved by X-ray diffraction methods and sharing a 61% sequence identity with human COX-2, was used as template. Both structures were energy minimized using the AMBER 4.0 force field with a dielectric constant of 4r. (S)-Flurbiprofen, a nonselective COX inhibitor; and SC-558, a COX-2-selective ligand, were docked at the cyclooxygenase binding site in both isozymes, evidencing the role of different residues in the ligand-protein interaction. The 3D structures of the constructed four ligand-enzyme complexes were refined by energy minimization. Molecular dynamics simulations were also carried out, to understand more deeply the structural origins of the selectivity. Distances calculated during the dynamics process between the different ligands and the interacting residues of the two PGHS isozymes provided evidence of the flexible nature of the cyclooxygenase active site, permitting the identification of different conserved and nonconserved residues as responsible for ligand selectivity. (C) 1998 by Elsevier Science Inc.
引用
收藏
页码:290 / 300
页数:11
相关论文
共 28 条
[1]   PURIFICATION, CHARACTERIZATION AND SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN-G/H SYNTHASE-1 AND SYNTHASE-2 EXPRESSED IN THE BACULOVIRUS SYSTEM [J].
BARNETT, J ;
CHOW, J ;
IVES, D ;
CHIOU, M ;
MACKENZIE, R ;
OSEN, E ;
NGUYEN, B ;
TSING, S ;
BACH, C ;
FREIRE, J ;
CHAN, H ;
SIGAL, E ;
RAMESHA, C .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (01) :130-139
[2]   Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1 [J].
Bhattacharyya, DK ;
Lecomte, M ;
Rieke, CJ ;
Garavito, RM ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2179-2184
[3]   THE RELATION BETWEEN THE DIVERGENCE OF SEQUENCE AND STRUCTURE IN PROTEINS [J].
CHOTHIA, C ;
LESK, AM .
EMBO JOURNAL, 1986, 5 (04) :823-826
[4]   VALPROIC ACID METABOLISM BY CYTOCHROME-P450 - A THEORETICAL-STUDY OF STEREOELECTRONIC MODULATORS OF PRODUCT DISTRIBUTION [J].
COLLINS, JR ;
CAMPER, DL ;
LOEW, GH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (07) :2736-2743
[5]   MECHANISM OF SELECTIVE-INHIBITION OF THE INDUCIBLE ISOFORM OF PROSTAGLANDIN G/H SYNTHASE [J].
COPELAND, RA ;
WILLIAMS, JM ;
GIANNARAS, J ;
NURNBERG, S ;
COVINGTON, M ;
PINTO, D ;
PICK, S ;
TRZASKOS, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11202-11206
[6]  
FRISCH MJ, 1995, GAUSSIAN94 REVISION
[7]   NS-398, A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG WITH POTENT ANALGESIC AND ANTIPYRETIC EFFECTS, WHICH CAUSES MINIMAL STOMACH LESIONS [J].
FUTAKI, N ;
YOSHIKAWA, K ;
HAMASAKA, Y ;
ARAI, I ;
HIGUCHI, S ;
IIZUKA, H ;
OTOMO, S .
GENERAL PHARMACOLOGY, 1993, 24 (01) :105-110
[8]   PROSTAGLANDIN-H SYNTHASE [J].
GARAVITO, RM ;
PICOT, D ;
LOLL, PJ .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (04) :529-535
[9]   A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors [J].
Gierse, JK ;
McDonald, JJ ;
Hauser, SD ;
Rangwala, SH ;
Koboldt, CM ;
Seibert, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15810-15814
[10]   EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLE FORMS OF HUMAN CYCLOOXYGENASE [J].
GIERSE, JK ;
HAUSER, SD ;
CREELY, DP ;
KOBOLDT, C ;
RANGWALA, SH ;
ISAKSON, PC ;
SEIBERT, K .
BIOCHEMICAL JOURNAL, 1995, 305 :479-484